The patients included in this study were adult fe¬ males (age >17 years) in whom a diagnosis of pi¬ tuitary driven Cushing's disease had been made on the basis of standard biochemical investigations (6,7). None had previously received external beam radiotherapy or pituitary surgery. All underwent interstitial irradiation of the pituitary gland using 90Y implants (5) 
It is commonly assumed that serum testosterone levels are elevated in patients with Cushing's dis¬ ease. In women with Cushing's syndrome, severe hirsutism and virilisation in association with an el¬ evated serum testosterone concentration is said to be more a feature of adrenal adenomas and carci¬ nomas than pituitary adenomas (1) , but hirsutism and acne were included by Cushing in his original series of patients with pituitary adenomas (2) and more recent series have estimated that these fea¬ tures occur in up to 80% of female patients with Cushing's syndrome (3, 4) . However, there have been no published studies of testosterone levels in a large unselected series of patients with proven pituitary driven Cushing's disease.
We have therefore reviewed the serum testoste¬ rone levels in our female patients whose diagnosis of pituitary driven Cushing's disease has been sub¬ stantiated by their entering into remission follow¬ ing treatment with interstitial irradiation of the pituitary gland (5) . The degree of hirsutism of these patients was also assessed, and this was compared with the serum testosterone concentration. Serum testosterone concentrations were also compared with the severity of corticotrope hyperfunction as assessed by the midnight plasma ACTH concen¬ tration.
Patients and Methods
The patients included in this study were adult fe¬ males (age >17 years) in whom a diagnosis of pi¬ tuitary driven Cushing's disease had been made on the basis of standard biochemical investigations (6, 7) . None had previously received external beam radiotherapy or pituitary surgery. All underwent interstitial irradiation of the pituitary gland using 90Y implants (5) androgens (11) , and with exception of dehydro¬ epiandrosterone are secreted in small quantities (12) . Furthermore, in normal women the majority of circulating testosterone is bound to protein (ap¬ proximately 66% to sex-hormone-binding globulin and 30% to albumin) (12) (13) (14) (18) (19) (20) (21) (22) , dehy¬ droepiandrosterone (20, 23, 24) and androstene¬ dione (18) (19) (20) 22, 24) . A direct effect of ACTH on testosterone secretion by isolated human adrenal cells has also been demonstrated (25) . In normal women there appears to be considerable variation in both the response of plasma androgen levels to exogenous ACTH (20) and in the threshold at which this response occurs (24) . Such variations to¬ gether with differences in the prevailing ACTH concentrations, may explain the range of testoste¬ rone concentrations found before treatment in our patients. They may also explain why the fall in cir¬ culating testosterone concentrations following dis¬ ease remission was most marked in those patients whose levels were elevated initially; ACTH levels may already be subthreshold for stimulation of an¬ drogen secretion in those patients with pre-treat¬ ment serum testosterone concentrations in the normal range. A separate adrenal androgen-stimulating glycopeptide may also be released from the pituitary gland (26) : however, the role of this factor and its relationship to elevated androgen levels in disease states have not been defined.
